Details for New Drug Application (NDA): 017736
✉ Email this page to a colleague
The generic ingredient in PAXIPAM is halazepam. There are two drug master file entries for this compound. Additional details are available on the halazepam profile page.
Summary for 017736
Tradename: | PAXIPAM |
Applicant: | Schering |
Ingredient: | halazepam |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Profile for product number 004
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 40MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Expired US Patents for NDA 017736
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Schering | PAXIPAM | halazepam | TABLET;ORAL | 017736-003 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Schering | PAXIPAM | halazepam | TABLET;ORAL | 017736-004 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription